Regeneron Pharmaceuticals REGN Bullish Investment Case Strengthens Post FDA Hearing Gene Therapy Approval Amid Temporary Share Pullback What JV transaction Odysightai ODYS Odysightai posts 1042 negative EPS surprise How Murphy Oil MUR talent strategy drives results Q4 2025 EPS Exceeds Expectations Flaherty FFC Resistance Levels Newmont Mining Corporation NEM Inherent Gold Sector Volatility Explains Recent Share Price Swings Investors Should Align Exposure With Risk Tolerance Is Brook BRP BEPI stock showing strength today WSFS WSFS posts 12 percent Q1 2026 earnings beat shares rise 115 percent on positive investor sentiment Eli Lilly and Company LLY Q1 2026 Earnings Beat Delivers Modest Revenue Forecast Upside Amid Sustained Sector Outperformance